Market News
Stay updated with the latest market trends, earnings, and economic indicators.
IndusInd Bank among 6 stocks to hit 52-week highs & rally up to 25% in a month
Six BSE 100 stocks, including Cholamandalam Investment, IndusInd Bank and Lupin, touched fresh 52-week highs as the Sensex climbed 521 points. The milestone reflects strong buying interest, positive momentum and growing investor confidence amid the broader market rally.
Glenmark Pharmaceuticals Ltd stays supported
Glenmark Pharmaceuticals Ltd is quoting at Rs 2260.5, up 2.24% on the day as on 12:49 IST on the NSE. The stock is up 21.53% in last one year as compared to a 4.02% slide in NIFTY and a 15.14% slide in the Nifty Pharma index.
Abbott India Ltd gains for fifth session
Abbott India Ltd is quoting at Rs 26830, up 3.61% on the day as on 12:44 IST on the NSE. The stock is down 22.2% in last one year as compared to a 3.99% gain in NIFTY and a 15.09% gain in the Nifty Pharma.
Stocks to buy or sell: Dharmesh Shah of ICICI Sec suggests buying Shriram Finance, Piramal Pharma shares on 6 July
Indian benchmark indices, Sensex and Nifty 50, opened higher on July 6, driven by gains in private banking stocks following strong quarterly updates from HDFC Bank and Axis Bank. Market breadth was positive with 14 of the 16 major indices in the green.
Sensex Today | Stock Market LIVE Updates: GIFT Nifty hints at a negative start; Sona BLW in focus
Sensex Today | Stock Market LIVE Updates: Nearly the entire market has reported its business update for the first quarter over the weekend, with companies ranging from banks, FMCG and even the diagnostics space. The bulls will take comfort from the fact that gains of the last two sessions have come without banks doing the heavy lifting.
Five Stocks To Buy: Biocon, IndusInd Bank, Angel One And More | July 6, 2026
Five stocks to buy on July 6.
Analysts back buy-on-dips strategy as Nifty targets 24,450–24,800
Indian stock market analysts are optimistic, anticipating the Nifty to continue its upward trend. They suggest buying on dips around the 24,000-24,150 mark, with potential upside targets reaching 24,800. Several stocks, including Container Corporation of India, IndusInd Bank, Biocon, HDFC Asset Management Company, Shriram Finance, and Piramal Pharma, are highlighted as strong buy recommendations with specific price targets and stop-losses.
Dalal Street also smokes peace pipe, ends in green for 4th week in row
Indian stock markets concluded their fourth consecutive week of gains, buoyed by declining crude oil prices and improved geopolitical sentiment. Analysts anticipate further upward movement for the Nifty 50, with upcoming quarterly earnings reports expected to guide market direction. Sectoral strength was observed in Realty, Pharma, Healthcare, and Cement, while broader market indices showed mixed performance. Foreign investors were net buyers, contrasting with domestic institutional selling.
Nifty Pharma rallies 2%; Laurus, Ipca, Aurobindo, Torrent hit record highs
In the past month, the Nifty Pharma index outperformed the market by surging 7.4 per cent, as compared to 4.2 per cent rise in the Nifty 50.
Rajesh Palviya of Axis Sec suggests Five-Star Business, Apollo Tyres, Exide Industries shares to buy today
Sensex and Nifty 50 surged on Friday, driven by IT stocks amid optimism from softer US jobs data. Nifty 50 rose 0.83% to 24,375.65, with 15 of 16 sectoral indices in the green, reflecting positive market sentiment despite ongoing global uncertainties.
Sensex gains 579 points, Nifty ends above 24,150: 5 reasons why stock market rose today
Indian indices rose, Sensex up 579 pts, Nifty above 24,150, led by IT stocks, oil companies. Bank of Baroda fell on NMC Health settlement.
Elara Securities turns bullish on banks, power, IT after market correction
Bino Pathiparampil, Head of Research, Elara Securities (India), says Indian markets are nearing a medium-term bottom after a prolonged correction and is turning constructive on banks, power, select new-age companies, IT and real estate. While pharma remains a defensive bet, he expects margin pressure to limit near-term outperformance. He also believes IT stocks are gradually pricing in AI-led headwinds, making it a good time to start accumulating quality names.